AstraZeneca pays $85M to Quell Type 1 diabetes with ‘one and done’ cell therapy – FierceBiotech

by

  1. AstraZeneca pays $85M to Quell Type 1 diabetes with ‘one and done’ cell therapy FierceBiotech
  2. AstraZeneca signs $2 billion agreement with Quell to develop cell therapies Reuters
  3. AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases AstraZeneca
  4. Quell Therapeutics Signs a Collaboration, Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases GlobeNewswire
  5. Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell Bloomberg

Read original article here

Leave a Comment